[ad_1] BOSTON and MONTREAL, Nov. 29, 2023 /PRNewswire/ – enGene Holdings Inc. (“enGene,”) (NASDAQ: ENGN) (NASDAQ: ENGNW), a clinical-stage genetic medicines company whose lead program is in a pivotal study…
Tag: enGene
enGene (Nasdaq: ENGN) Launched as Publicly Traded Genetic Medicines Company
[ad_1] Business combination transaction completed with Forbion European Acquisition Corp. Clinical stage biotechnology company with EG-70 lead program in pivotal clinical study targeting BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) $138M…
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
[ad_1] BOSTON and MONTREAL, Sept. 7, 2023 /PRNewswire/ – enGene, Inc., a clinical-stage biotechnology company mainstreaming gene therapy through its novel platform for the delivery of therapeutics to mucosal tissues…